Free tool
FAERS Monitor: Humulin R Pen
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming BLA 018780 or its brand name (Humulin R Pen, Insulin Recombinant Human, Insulin Human). Reports on generic versions are filed under their own applications.
Reports
20,477
Serious
14,713
72% of reports
Hospitalization
8,296
Death reported
2,078
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- blood glucose increased4,701
- blood glucose decreased1,664
- drug ineffective1,594
- hypoglycaemia1,033
- wrong technique in product usage process875
- nausea835
- diarrhoea820
- dyspnoea795
- incorrect dose administered739
- weight decreased695
- fall687
- vomiting673
- headache648
- hyperglycaemia632
- fatigue627
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 619 |
| 2005 | 706 |
| 2006 | 634 |
| 2007 | 402 |
| 2008 | 426 |
| 2009 | 623 |
| 2010 | 636 |
| 2011 | 615 |
| 2012 | 665 |
| 2013 | 555 |
| 2014 | 740 |
| 2015 | 2,669 |
| 2016 | 1,018 |
| 2017 | 1,067 |
| 2018 | 1,142 |
| 2019 | 1,126 |
| 2020 | 1,087 |
| 2021 | 1,063 |
| 2022 | 1,155 |
| 2023 | 1,016 |
| 2024 | 960 |
| 2025 | 944 |
| 2026 | 609 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,033,682 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| blood glucose decreasedSignal | 1,664 | 36.8 | 35.1 | 56,093 |
| blood glucose increasedSignal | 4,701 | 26.3 | 25.6 | 112,350 |
| hypoglycaemiaSignal | 1,033 | 22.3 | 21.0 | 20,626 |
| hyperglycaemiaSignal | 632 | 18.1 | 16.8 | 10,041 |
| wrong technique in product usage processSignal | 875 | 4.5 | 4.2 | 2,350 |
| incorrect dose administeredSignal | 739 | 3.3 | 3.1 | 1,214 |
| weight decreasedSignal | 695 | 2.6 | 2.4 | 667 |
| fallSignal | 687 | 2.1 | 2.0 | 412 |
| vomiting | 673 | 1.5 | 1.4 | 103 |
| dyspnoea | 795 | 1.4 | 1.3 | 111 |
| diarrhoea | 820 | 1.3 | 1.2 | 60 |
| drug ineffective | 1,594 | 1.2 | 1.2 | 80 |
| nausea | 835 | 1.1 | 1.0 | 6 |
| headache | 648 | 1.1 | 1.0 | 2 |
| fatigue | 627 | 0.8 | 0.8 | 23 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.